Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 56 pages report, published by Global Markets Direct

Report ThumbnailJune-2017
Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2017, provides an overview of the Middle East Respiratory Syndrome (MERS) (Infectious Disease) pipeline landscape.

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERSCoV). Symptoms include fever, cough and shortness of breath.

Read More
  • List of Figures
  • Number of Products under Development for Middle East Respiratory Syndrome (MERS), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products by Targets, H1 2017
  • Number of Products by Stage and Targets, H1 2017
  • Number of Products by Mechanism of Actions, H1 2017
  • Number of Products by Stage and Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration, H1 2017
  • Number of Products by Stage and Routes of Administration, H1 2017
  • Number of P
Read More
  • List of Tables
  • Number of Products under Development for Middle East Respiratory Syndrome (MERS), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Products under Development by Companies, H1 2017
  • Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Stage and Target, H1 2017
  • Number of Products by Stage and Mechanism of Action, H1 2017
  • Number of Products by Stage and Route of A
Read More
  • Table of Contents
  • List of Tables
  • List of Figures
  • Introduction
  • Global Markets Direct Report Coverage
  • Middle East Respiratory Syndrome (MERS) - Overview
  • Middle East Respiratory Syndrome (MERS) - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Pipeline by Universities/Institutes
  • Products under Development by Companies
  • Products under Development by Universities/Institutes
  • Middle East Respiratory Syndrome (MERS) - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism o
Read More

Please select a license type

Share

Related Products

Global Markets DirectMiddle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2017Product ThumbnailMiddle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2017, Industry ReportProduct #: 829010
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved